OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions
Milo Gatti, Federico Pea
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 11, pp. 1519-1544
Open Access | Times Cited: 22
Milo Gatti, Federico Pea
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 11, pp. 1519-1544
Open Access | Times Cited: 22
Showing 22 citing articles:
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
Arthur Géraud, Thomas Hueso, Ariane Laparra, et al.
European Journal of Cancer (2024) Vol. 205, pp. 114075-114075
Closed Access | Times Cited: 9
Arthur Géraud, Thomas Hueso, Ariane Laparra, et al.
European Journal of Cancer (2024) Vol. 205, pp. 114075-114075
Closed Access | Times Cited: 9
Characterization of Renal OAT3 and Hepatic CYP3A Activities in Pregnant Women with Acute Pyelonephritis Using the Endogenous Biomarker Cortisol and 6β‐Hydroxycortisol
João Paulo Bianchi Ximenez, Jhohann Richard de Lima Benzi, Julia Cristina Colombari, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
João Paulo Bianchi Ximenez, Jhohann Richard de Lima Benzi, Julia Cristina Colombari, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
LEPR gene polymorphisms and pneumonia risk in Taiwanese schizophrenia patients under clozapine treatment
Hui-Ching Huang, Bojian Wu, Chuan-Hsun Yu, et al.
Schizophrenia Research (2025) Vol. 278, pp. 1-8
Closed Access
Hui-Ching Huang, Bojian Wu, Chuan-Hsun Yu, et al.
Schizophrenia Research (2025) Vol. 278, pp. 1-8
Closed Access
Intestinal dysbiosis alters acute seizure burden and antiseizure medicine activity in Theiler's virus model of encephalitis
Inga Erickson, Stephanie Davidson, Hanna Choi, et al.
Epilepsia (2025)
Open Access
Inga Erickson, Stephanie Davidson, Hanna Choi, et al.
Epilepsia (2025)
Open Access
The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review
Letao Li, Julia Zinger, Sebastiaan D. T. Sassen, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Letao Li, Julia Zinger, Sebastiaan D. T. Sassen, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
Milo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
Antibiotics (2023) Vol. 12, Iss. 4, pp. 764-764
Open Access | Times Cited: 7
Milo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
Antibiotics (2023) Vol. 12, Iss. 4, pp. 764-764
Open Access | Times Cited: 7
Physiologically Based Pharmacokinetic Modeling to Investigate the Disease‐Drug–Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID ‐19 Patients with CYP2C19 Phenotypes
Peile Wang, Shuaibing Liu, Jing Yang
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 2, pp. 363-371
Closed Access | Times Cited: 2
Peile Wang, Shuaibing Liu, Jing Yang
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 2, pp. 363-371
Closed Access | Times Cited: 2
Population pharmacokinetic modeling of sufentanil in adult Korean patients undergoing cardiopulmonary bypass surgery
Vipada Khaowroongrueng, Kuk Hui Son, Sang‐Min Lee, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 10, pp. 1682-1692
Open Access | Times Cited: 2
Vipada Khaowroongrueng, Kuk Hui Son, Sang‐Min Lee, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 10, pp. 1682-1692
Open Access | Times Cited: 2
Rare oncology therapeutics: review of clinical pharmacology package of drug approvals (2019–2023) by US FDA, best practices and recommendations
Amitava Mitra, Jong Bong Lee, Douglas Steinbach, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2023) Vol. 50, Iss. 6, pp. 475-493
Closed Access | Times Cited: 6
Amitava Mitra, Jong Bong Lee, Douglas Steinbach, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2023) Vol. 50, Iss. 6, pp. 475-493
Closed Access | Times Cited: 6
The combination of CYP2C19 polymorphism and inflammatory cell ratios in prognosis cardiac adverse events after acute coronary syndrome
Toan Hoang Ngo, Nha Tran Khuong Nguyen, Nga Thi Ngoc Pham, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2023) Vol. 19, pp. 200222-200222
Open Access | Times Cited: 5
Toan Hoang Ngo, Nha Tran Khuong Nguyen, Nga Thi Ngoc Pham, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2023) Vol. 19, pp. 200222-200222
Open Access | Times Cited: 5
The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan
Milo Gatti, Federico Pea
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1035-1051
Closed Access | Times Cited: 5
Milo Gatti, Federico Pea
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1035-1051
Closed Access | Times Cited: 5
Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT
Milo Gatti, Caterina Campoli, Edoardo Muratore, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1388-1388
Open Access | Times Cited: 1
Milo Gatti, Caterina Campoli, Edoardo Muratore, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1388-1388
Open Access | Times Cited: 1
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin
H. Abdullah-Koolmees, Julia F van den Nieuwendijk, Simone M K Ten Hoope, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 6, pp. 689-699
Open Access | Times Cited: 1
H. Abdullah-Koolmees, Julia F van den Nieuwendijk, Simone M K Ten Hoope, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 6, pp. 689-699
Open Access | Times Cited: 1
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of CYP2C8 Substrate Repaglinide in Humans
Mikael O.W. Piha, Kristiina Cajanus, Marica T. Engström, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 12, pp. 1388-1395
Open Access | Times Cited: 1
Mikael O.W. Piha, Kristiina Cajanus, Marica T. Engström, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 12, pp. 1388-1395
Open Access | Times Cited: 1
Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities
Jin Niu, Weirong Wang, Danièle Ouellet
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 977-990
Closed Access | Times Cited: 3
Jin Niu, Weirong Wang, Danièle Ouellet
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 977-990
Closed Access | Times Cited: 3
Evaluating drug-drug interaction risk associated with peptide analogues using advancedin vitrosystems
Rune Aa Nørgaard, D. Bhatt, Erkka Järvinen, et al.
Drug Metabolism and Disposition (2023), pp. DMD-001441
Open Access | Times Cited: 3
Rune Aa Nørgaard, D. Bhatt, Erkka Järvinen, et al.
Drug Metabolism and Disposition (2023), pp. DMD-001441
Open Access | Times Cited: 3
IL-17A activates JAK/STAT signaling to affect drug metabolizing enzymes and transporters in HepaRG cells
Yuanyuan Li, Nan Guo, Yinyu Zhao, et al.
Molecular Immunology (2024) Vol. 175, pp. 55-62
Closed Access
Yuanyuan Li, Nan Guo, Yinyu Zhao, et al.
Molecular Immunology (2024) Vol. 175, pp. 55-62
Closed Access
Intestinal Dysbiosis Alters Acute Seizure Burden and Antiseizure Medicine Activity in the Theiler's Virus Model of Encephalitis
Inga Erickson, Stephanie Davidson, Hanna Choi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Inga Erickson, Stephanie Davidson, Hanna Choi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Noise - an insidious stressor affecting xenobiotic metabolism?
R. H. Waring, Stephen Mitchell
Xenobiotica (2024) Vol. 55, Iss. 1, pp. 1-3
Open Access
R. H. Waring, Stephen Mitchell
Xenobiotica (2024) Vol. 55, Iss. 1, pp. 1-3
Open Access
Pharmakokinetik und Arzneimittelinteraktionen
Christoph Hiemke, Gudrun Hefner, Otto Benkert
Springer eBooks (2023), pp. 991-1010
Closed Access | Times Cited: 1
Christoph Hiemke, Gudrun Hefner, Otto Benkert
Springer eBooks (2023), pp. 991-1010
Closed Access | Times Cited: 1
A machine learning-based approach to prognostic model of sepsis with PANoptosis-related genes and performance of scRNA-seq data to assess prognostic signatures
Jinglin Shao, Haihong He, Tingting Huang, et al.
Research Square (Research Square) (2023)
Open Access
Jinglin Shao, Haihong He, Tingting Huang, et al.
Research Square (Research Square) (2023)
Open Access
Pharmacology of Tyrosine Kinase Inhibitors
Anne Hulin, Thibaut Gelé, Charlotte Fenioux, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 19, Iss. 7, pp. 927-938
Open Access
Anne Hulin, Thibaut Gelé, Charlotte Fenioux, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 19, Iss. 7, pp. 927-938
Open Access
